NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which drug is associated with a risk of agranulocytosis requiring REMS?

Aripiprazole
Lurasidone
Clozapine
Risperidone

The correct answer is: Clozapine

Clozapine is associated with a risk of agranulocytosis, a potentially life-threatening condition where the body does not produce enough white blood cells. As a result, Clozapine is required to have a Risk Evaluation and Mitigation Strategy (REMS) in place to monitor patients for this side effect. Aripiprazole, Lurasidone, and Risperidone do not carry this risk and therefore do not require REMS.